Skip to content

Lineage, Inc. LINE Cumulative Gross Losses and Impairments

Cumulative Gross Losses and Impairments at other companies

The Carlyle Group logo
The Carlyle GroupCG
$53.6M+261%
Valley National Bank logo
Valley National BankVLY
$6.72M+32.9%
Chimera Investment Corp. logo
Chimera Investment Corp.CIM
$113.09M-2.6%
Chimera Investment Corp. logo
Chimera Investment Corp.CIM
$58.26M+112%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
-$16.5M-271%
Ares Capital logo
Ares CapitalARCC
$1B-33.3%

Other financials

Income statement

See full
Revenue$1.3B+0.4%
Gross profit$417.0M+0.2%
Operating income$36.0M-35.7%
Net income-$46.0M
EPS (diluted)-$0.18-1,900%

Balance sheet

See full
Cash & equivalents$67.0M-66.0%
Total debt$8.2B+13.2%
Total equity$8.1B-5.8%
Total assets$19.0B+1.5%

Cash flow

See full
Operating cash flow$130.0M-6.5%
CapEx$185.0M+22.5%
Free cash flow-$55.0M-358%

Valuation

See full
Market cap$9.42B-44.4%
Enterprise value$17.55B-23.8%
P/S1.8×-1.4×

Profitability

See full
Gross margin32.1%-0.6pp
Operating margin3%+1.7pp
Net margin-2.8%-1.2pp
FCF margin2.9%+2.1pp

Returns & leverage

See full
Return on equity-1.8%-0.8pp
Debt / equity+0.2×
Current ratio0.8×-0.1×

Where this comes from

Reported directly by Lineage, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairedAccumulatedImpairmentLoss.

The official record: Lineage, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lineage, Inc.'s cumulative gross losses and impairments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lineage, Inc.'s cumulative gross losses and impairments?
Lineage, Inc. (LINE) reported cumulative gross losses and impairments of $48M in Q1 2026.